Top 10 Compounding Pharmacies for Retatrutide (2026)

Last updated: August 2026 | Researched and written by the Newtropin Editorial Team

Retatrutide has generated more search interest than almost any other metabolic compound of the last two years, driven by trial results reporting weight reduction exceeding what earlier incretin agents achieved. That interest has produced a large volume of searches for compounded sourcing — and a market willing to serve them regardless of regulatory position.

Before the rankings, the regulatory picture, because for this specific compound it determines whether the question is even the right one.

Read This First: Retatrutide's Regulatory Status

Retatrutide is an investigational drug. It is not FDA-approved for any indication and remains in clinical development.

That status carries a direct consequence for compounding. A 503A pharmacy may generally compound using a bulk drug substance only where that substance is a component of an FDA-approved drug, has an applicable USP monograph, or appears on the FDA's 503A Bulks List. An investigational compound that satisfies none of these does not have a clear lawful path to 503A compounding.

This is materially different from the situation with semaglutide or tirzepatide, both of which are components of approved drugs — and where compounding has been permitted mainly under shortage conditions that have since changed.

What this means practically: a pharmacy advertising compounded retatrutide today is operating in a space the FDA has not sanctioned. Some suppliers marketing it are not pharmacies at all, but research-chemical vendors using pharmacy-adjacent language.

Our detailed analysis of retatrutide compounding access and legality covers the regulatory position in full, and the retatrutide peptide profile covers the pharmacology.

The rankings below therefore assess pharmacies on their capability and standards for triple-agonist and advanced GLP-1 protocols generally — the pharmacies you would work with as the regulatory picture develops — not as an endorsement that any given compound is currently available.

How We Selected These Pharmacies

Our editorial team evaluated compounding pharmacies against the criteria that actually differentiate quality in advanced GLP-1 and incretin compounding:

• State licensing and 503A compliance — verified active licensure and adherence to Section 503A requirements
• USP 797 and 800 sterile compounding standards — clean-room classification, environmental monitoring, and aseptic technique validation
• Third-party analytical testing — potency, sterility, and endotoxin testing on dispensed lots
• Regulatory transparency — willingness to state clearly what may and may not be compounded under current FDA positions
• Provider support — prescriber education, dosing guidance, and dedicated account management
• Cold-chain logistics — validated temperature-controlled shipping for sensitive preparations
• Regulatory track record — inspection history, warning letters, and recall record

The Rankings

1. Newtropin

Known For: Provider-focused peptide and metabolic compounding partnership with active regulatory monitoring.

Key Strengths:

• Real-time FDA status monitoring across the incretin and peptide categories, so providers are not prescribing into a changed regulatory position
• Partnership with a licensed 503A compounding pharmacy operating under USP 797 and 800 standards
• Third-party analytical verification and certificates of analysis available to prescribing providers
• Nationwide cold-chain shipping with insulated packaging and temperature indicators
• Dedicated provider support including dosing references and account management

Notable: On retatrutide specifically, our position is the one stated above — we will tell providers plainly when a compound lacks a lawful 503A pathway rather than take the order. For metabolic protocols available now, our team works with prescribers on approved and compoundable alternatives.

2. Empower Pharmacy

Known For: High-volume compounding operation with a broad metabolic and hormone formulary.

Key Strengths:

• Substantial scale in sterile injectable compounding
• Established provider ordering infrastructure
• Broad metabolic and weight-management formulary

Notable: Confirm current availability and regulatory position on any incretin compound directly with the pharmacy.

3. LS Compounding

Known For: Peptide-focused compounding with third-party verification.

Key Strengths:

• Peptides are a headline category rather than a secondary line
• Third-party laboratory testing on dispensed products
• Rapid fulfillment for time-sensitive preparations

Notable: Verify current incretin availability directly — positions across this category have shifted repeatedly.

4. Hallandale Pharmacy

Known For: Sterile compounding with an established prescriber network.

Key Strengths:

• Sterile injectable capability
• Established telehealth and clinic relationships
• Metabolic and hormone formulary depth

Notable: Ask specifically about analytical testing documentation for any injectable preparation.

5. Olympia Pharmaceuticals

Known For: Broad sterile compounding across metabolic and wellness categories.

Key Strengths:

• Wide formulary spanning metabolic, hormone, and wellness preparations
• Provider-oriented ordering and support
• Nationwide distribution capability

Notable: Confirm cold-chain handling for any temperature-sensitive preparation.

6. Belmar Pharma Solutions

Known For: Hormone and metabolic compounding with a clinical-support emphasis.

Key Strengths:

• Long-standing hormone compounding experience
• Clinical education resources for prescribers
• Individualized formulation capability

Notable: Strong option where a protocol requires non-standard concentrations.

7. Strive Pharmacy

Known For: Personalized compounding with a direct provider relationship model.

Key Strengths:

• Individualized formulation focus
• Responsive provider communication
• Multi-state licensure

Notable: Confirm state licensure covers your practice location.

8. Wells Pharmacy Network

Known For: Multi-facility compounding with wellness and metabolic focus.

Key Strengths:

• Multiple compounding facilities
• Wellness and metabolic formulary
• Established provider ordering systems

Notable: Verify which facility fills your prescription and its accreditation status.

9. Tailor Made Compounding

Known For: Peptide-centric compounder with telehealth integration.

Key Strengths:

• Large peptide catalog
• Sterile compounding in ISO-classified clean rooms
• Established telehealth platform partnerships

Notable: Popular with cash-pay metabolic and regenerative clinics.

10. APS Pharmacy

Known For: Independent compounding with personalized clinical service.

Key Strengths:

• Individualized formulation and consultation
• Hormone and metabolic capability
• Direct pharmacist access for prescribers

Notable: Smaller-scale operation with correspondingly direct communication.

What to Do Instead, Right Now

For patients and providers pursuing incretin-based metabolic therapy today, the defensible options are FDA-approved products with approved indications, or compounded preparations with a clear regulatory basis. Our comparison of semaglutide, tirzepatide, and retatrutide covers where each currently stands, and the top compounding pharmacies for semaglutide and GLP-1 therapy covers that category specifically.

Before You Choose

Accreditation and testing claims are verifiable — ask for them. A pharmacy that will provide a certificate of analysis, name its testing laboratory, and state its licensure clearly is telling you something meaningful about how it operates. Our guide to choosing a quality compounding pharmacy covers what to ask, and our FDA peptide status tracker tracks what is currently compoundable.

Newtropin is a nutraceutical and wellness marketing firm that connects healthcare providers with a licensed 503A compounding partner. We are not a pharmacy and do not compound or dispense.

Frequently Asked Questions

Can you get compounded retatrutide legally?

Retatrutide is investigational and not FDA-approved. It is not a component of an approved drug, has no applicable USP monograph, and is not on the FDA's 503A Bulks List — so there is no clear lawful pathway for 503A compounding. Suppliers advertising it are operating outside sanctioned territory, and many are not pharmacies at all.

Why is retatrutide different from compounded semaglutide?

Semaglutide and tirzepatide are components of FDA-approved drugs, which is what made compounding possible under specific conditions, primarily drug shortages. Retatrutide has no approved form at all, so that basis does not exist.

What should I look for in a GLP-1 compounding pharmacy?

Verified state licensure, USP 797 compliance for sterile injectables, third-party potency and sterility testing with available certificates of analysis, validated cold-chain shipping, and a clear willingness to state what it can and cannot lawfully compound.

Is research-grade retatrutide safe to use?

Material sold as "research use only" is not manufactured, tested, or sold as medicine. There is no assurance of identity, purity, concentration, or sterility, and that labeling is what permits its sale. It should not be used in humans.

When might compounded retatrutide become available?

That depends on FDA approval and subsequent regulatory decisions, neither of which can be predicted. Our FDA peptide status tracker is updated as determinations are published.

What are the alternatives available now?

FDA-approved GLP-1 and dual-agonist products with approved indications are the clearest route. Our complete guide to semaglutide, tirzepatide, and retatrutide compares them.